Work

Supercritical fluid technology based large porous celecoxib–PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose

Year: 2013

Type: article

Source: Journal of Controlled Release

DOI: 10.1016/j.jconrel.2013.03.027

Authors: Devender S. Dhanda, Puneet Tyagi, Sidney S. Mirvish, Uday B. Kompella

Institutions: University of Nebraska Medical Center, University of Colorado Anschutz

Language: English

Topic: Inhalation and Respiratory Drug Delivery

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: American Heart Association, University of Nebraska Medical Center, National Institutes of Health, National Eye Institute

Awards: G186879587, Transcleral Therapeutics in Diabetic Retinopathy, Delivery of LEDGF for retinal degenerative disorders, G7043484253

OpenAlex ID: W1992445150

FWCI: 5.145

Cites: 72

Cited by: 56

Related to: 10